Source: Vaccines. Unidades: EP, EACH
Assunto: VÍRUS DA RAIVA
ABNT
GUARDALINI, Luis Giovani Oliveira et al. Performance comparison of recombinant baculovirus and rabies virus-like particles production using two culture platforms. Vaccines, v. 11, n. 1, p. 01-21, 2023Tradução . . Disponível em: https://doi.org/10.3390/vaccines11010039. Acesso em: 01 nov. 2024.APA
Guardalini, L. G. O., Cavalcante, P. E. da S., Leme, J., Mello, R. G. de, Bernardino, T. C., Jared, S. G. S., et al. (2023). Performance comparison of recombinant baculovirus and rabies virus-like particles production using two culture platforms. Vaccines, 11( 1), 01-21. doi:10.3390/vaccines11010039NLM
Guardalini LGO, Cavalcante PE da S, Leme J, Mello RG de, Bernardino TC, Jared SGS, Antoniazzi MM, Astray RM, Tonso A, Fernández Núñez EG, Jorge SAC. Performance comparison of recombinant baculovirus and rabies virus-like particles production using two culture platforms [Internet]. Vaccines. 2023 ; 11( 1): 01-21.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/vaccines11010039Vancouver
Guardalini LGO, Cavalcante PE da S, Leme J, Mello RG de, Bernardino TC, Jared SGS, Antoniazzi MM, Astray RM, Tonso A, Fernández Núñez EG, Jorge SAC. Performance comparison of recombinant baculovirus and rabies virus-like particles production using two culture platforms [Internet]. Vaccines. 2023 ; 11( 1): 01-21.[citado 2024 nov. 01 ] Available from: https://doi.org/10.3390/vaccines11010039